A short discourse on vascular tissue engineering

Vascular tissue engineering has significant potential to make a major impact on a wide array of clinical problems. Continued progress in understanding basic vascular biology will be invaluable in making further advancements. Past and current achievements in tissue engineering of microvasculature to perfuse organ specific constructs, small vessels for dialysis grafts, and modified synthetic and pediatric large caliber-vessel grafts will be discussed. An emphasis will be placed on clinical trial results with small and large-caliber vessel grafts. Challenges to achieving engineered constructs that satisfy the physiologic, immunologic, and manufacturing demands of engineered vasculature will be explored.

[1]  J. Pober,et al.  Human aortic smooth muscle cells promote arteriole formation by coengrafted endothelial cells. , 2009, Tissue engineering. Part A.

[2]  J Hartikainen,et al.  Progress and prospects: hurdles to cardiovascular gene therapy clinical trials , 2011, Gene Therapy.

[3]  J. Guyette,et al.  Regeneration and Experimental Orthotopic Transplantation of a Bioengineered Kidney , 2013, Nature Medicine.

[4]  Hiroshi Yagi,et al.  Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix , 2010, Nature Medicine.

[5]  Takanori Takebe,et al.  Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant , 2014, Nature Protocols.

[6]  Randy L Carter,et al.  Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review. , 2003, Journal of vascular surgery.

[7]  Hyunjae Lee,et al.  Engineering of functional, perfusable 3D microvascular networks on a chip. , 2013, Lab on a chip.

[8]  R. Jain,et al.  Engineered blood vessel networks connect to host vasculature via wrapping-and-tapping anastomosis. , 2011, Blood.

[9]  E Bell,et al.  A blood vessel model constructed from collagen and cultured vascular cells. , 1986, Science.

[10]  Takanori Takebe,et al.  Vascularized and functional human liver from an iPSC-derived organ bud transplant , 2013, Nature.

[11]  Y. Imai,et al.  Transplantation of a tissue-engineered pulmonary artery. , 2001, The New England journal of medicine.

[12]  M S Conte,et al.  The ideal small arterial substitute: a search for the Holy Grail? , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  Ali Khademhosseini,et al.  Vascularization and Angiogenesis in Tissue Engineering: Beyond Creating Static Networks. , 2016, Trends in biotechnology.

[14]  Frank P T Baaijens,et al.  In Situ Tissue Engineering of Functional Small-Diameter Blood Vessels by Host Circulating Cells Only. , 2015, Tissue engineering. Part A.

[15]  Douglas Losordo,et al.  Therapeutic angiogenesis for critical limb ischemia: microvascular therapies coming of age. , 2008, Circulation.

[16]  L. Norgren,et al.  Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia , 2011, The Lancet.

[17]  Narutoshi Hibino,et al.  Tissue-engineered Vascular Grafts Demonstrate Evidence of Growth and Development When Implanted in a Juvenile Animal Model , 2008, Annals of surgery.

[18]  Narutoshi Hibino,et al.  Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling , 2010, Proceedings of the National Academy of Sciences.

[19]  S. Attanasio,et al.  Therapeutic Angiogenesis in the Management of Critical Limb Ischemia: Current Concepts and Review , 2009, Cardiology in review.

[20]  G Tellides,et al.  In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Yu-Hsiang Hsu,et al.  In vitro perfused human capillary networks. , 2013, Tissue engineering. Part C, Methods.

[22]  Robert T Tranquillo,et al.  Implantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring. , 2011, Biomaterials.

[23]  Dai Fukumura,et al.  Tissue engineering: Creation of long-lasting blood vessels , 2004, Nature.

[24]  Wayne A Morrison,et al.  An arteriovenous loop in a protected space generates a permanent, highly vascular, tissue‐engineered construct , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  Christian Schuetz,et al.  Regeneration and orthotopic transplantation of a bioartificial lung , 2010, Nature Medicine.

[26]  Todd N. McAllister,et al.  The Evolution of Vascular Tissue Engineering and Current State of the Art , 2011, Cells Tissues Organs.

[27]  Robert T Tranquillo,et al.  Implantation of completely biological engineered grafts following decellularization into the sheep femoral artery. , 2014, Tissue engineering. Part A.

[28]  Zhen W. Zhuang,et al.  Tissue-Engineered Lungs for in Vivo Implantation , 2010, Science.

[29]  Yadong Wang,et al.  Therapeutic angiogenesis: controlled delivery of angiogenic factors. , 2012, Therapeutic delivery.

[30]  Yasuko Tomizawa,et al.  Autocrine angiogenic vascular prosthesis with bone marrow transplantation , 1996, Nature Medicine.

[31]  R W Hallin,et al.  The Sparks' mandril graft. A seven year follow-up of mandril grafts placed by Charles H. Sparks and his associates. , 1976, American journal of surgery.

[32]  Ali Khademhosseini,et al.  3D Bioprinting for Tissue and Organ Fabrication , 2016, Annals of Biomedical Engineering.

[33]  James G Truslow,et al.  Effect of mechanical factors on the function of engineered human blood microvessels in microfluidic collagen gels. , 2010, Biomaterials.

[34]  A. Lumsden,et al.  Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass. , 2015, Journal of vascular surgery.

[35]  Lucie Germain,et al.  Inosculation of Tissue‐Engineered Capillaries with the Host's Vasculature in a Reconstructed Skin Transplanted on Mice , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[36]  C H Sparks,et al.  Autogenous grafts made to order. , 1969, The Annals of thoracic surgery.

[37]  F. Vermassen,et al.  Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[38]  Narutoshi Hibino,et al.  Successful application of tissue engineered vascular autografts: clinical experience. , 2003, Biomaterials.

[39]  N Famaey,et al.  Cyclically stretching developing tissue in vivo enhances mechanical strength and organization of vascular grafts. , 2010, Acta biomaterialia.

[40]  A Arkudas,et al.  A new approach to tissue engineering of vascularized skeletal muscle , 2006, Journal of cellular and molecular medicine.

[41]  E. Brogi,et al.  Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. , 1994, The Journal of clinical investigation.

[42]  Beverley Rader Lugo,et al.  Clinical Experience , 2009 .

[43]  Marcin Maruszewski,et al.  Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study , 2009, The Lancet.

[44]  J. Cooke,et al.  Stem Cell Therapy for Vascular Regeneration: Adult, Embryonic, and Induced Pluripotent Stem Cells , 2010, Circulation.

[45]  R Langer,et al.  Functional arteries grown in vitro. , 1999, Science.

[46]  S. Mahooti,et al.  Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. , 1998, Journal of cell science.

[47]  J. Pober,et al.  Participation of blood vessel cells in human adaptive immune responses. , 2012, Trends in immunology.

[48]  D. Kohane,et al.  Engineering vascularized skeletal muscle tissue , 2005, Nature Biotechnology.

[49]  Ying Zheng,et al.  In vitro microvessels for the study of angiogenesis and thrombosis , 2012, Proceedings of the National Academy of Sciences.

[50]  Matthias W Laschke,et al.  Prevascularization in tissue engineering: Current concepts and future directions. , 2016, Biotechnology advances.

[51]  Silviu Itescu,et al.  Cardiac Tissue Engineering in an In Vivo Vascularized Chamber , 2007, Circulation.

[52]  Napoleone Ferrara,et al.  Clinical applications of angiogenic growth factors and their inhibitors , 1999, Nature Medicine.

[53]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[54]  J. Pober,et al.  Efficient gene disruption in cultured primary human endothelial cells by CRISPR/Cas9. , 2015, Circulation research.

[55]  Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials , 2016, The Lancet.

[56]  Ali Khademhosseini,et al.  Microfluidic techniques for development of 3D vascularized tissue. , 2014, Biomaterials.

[57]  Brendon M. Baker,et al.  Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues , 2012 .

[58]  Brendon M. Baker,et al.  Rapid casting of patterned vascular networks for perfusable engineered 3D tissues , 2012, Nature materials.

[59]  Brenda Baggett,et al.  Large-scale time series microscopy of neovessel growth during angiogenesis , 2015, Angiogenesis.

[60]  A. Khademhosseini,et al.  Micro fl uidic techniques for development of 3 D vascularized tissue , 2015 .

[61]  Ulrich Kneser,et al.  Axial prevascularization of porous matrices using an arteriovenous loop promotes survival and differentiation of transplanted autologous osteoblasts. , 2007, Tissue engineering.

[62]  J. Pober,et al.  Blocking MHC class II on human endothelium mitigates acute rejection. , 2016, JCI insight.

[63]  Laure Gibot,et al.  A preexisting microvascular network benefits in vivo revascularization of a microvascularized tissue-engineered skin substitute. , 2010, Tissue engineering. Part A.

[64]  J. Pober,et al.  Pericytes modulate endothelial sprouting. , 2013, Cardiovascular research.

[65]  Stefanie Dimmeler,et al.  Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. , 2004, Circulation.

[66]  Andreas Hess,et al.  De novo generation of axially vascularized tissue in a large animal model , 2009, Microsurgery.

[67]  Dai Fukumura,et al.  Engineering vascularized tissue , 2005, Nature Biotechnology.

[68]  Dai Fukumura,et al.  Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. , 2008, Blood.

[69]  Doris A Taylor,et al.  Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart , 2008, Nature Medicine.

[70]  Jinfen Liu,et al.  Development of the novel biotube inserting technique for acceleration of thick-walled autologous tissue-engineered vascular grafts fabrication , 2011, Journal of materials science. Materials in medicine.

[71]  J. Pober,et al.  Explant Outgrowth, Propagation and Characterization of Human Pericytes , 2010, Microcirculation.

[72]  R. Jain,et al.  Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells , 2013, Proceedings of the National Academy of Sciences.

[73]  Narutoshi Hibino,et al.  Late-term results of tissue-engineered vascular grafts in humans. , 2010, The Journal of thoracic and cardiovascular surgery.

[74]  P. Carmeliet,et al.  Molecular mechanisms and clinical applications of angiogenesis , 2011, Nature.

[75]  Laura E Niklason,et al.  Readily Available Tissue-Engineered Vascular Grafts , 2011, Science Translational Medicine.